GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
GenWorks has scaled up its e-commerce platform in terms of building traffic
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Augnito’s AI comprehends all English accents with 99% accuracy
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
This partnership will revolutionize Pharmarack's digital infrastructure with Snowflake's single, integrated platform to facilitate advanced analytic
Subscribe To Our Newsletter & Stay Updated
